NICOLI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 4.135
AS - Asia 2.373
EU - Europa 1.585
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 56
OC - Oceania 8
Totale 8.739
Nazione #
US - Stati Uniti d'America 3.982
SG - Singapore 943
IT - Italia 783
CN - Cina 475
BR - Brasile 311
VN - Vietnam 275
HK - Hong Kong 196
DE - Germania 137
GB - Regno Unito 119
BD - Bangladesh 108
FI - Finlandia 82
FR - Francia 81
ID - Indonesia 75
CA - Canada 74
PL - Polonia 72
IN - India 65
JP - Giappone 60
NL - Olanda 58
UA - Ucraina 55
TR - Turchia 51
RU - Federazione Russa 48
AR - Argentina 46
MX - Messico 41
SE - Svezia 35
BE - Belgio 20
CO - Colombia 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 17
SA - Arabia Saudita 16
AT - Austria 15
EC - Ecuador 11
VE - Venezuela 11
IE - Irlanda 10
MA - Marocco 10
PK - Pakistan 10
UZ - Uzbekistan 10
JM - Giamaica 9
PH - Filippine 9
CZ - Repubblica Ceca 8
IR - Iran 8
EE - Estonia 7
KE - Kenya 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CH - Svizzera 6
CL - Cile 6
CR - Costa Rica 6
LT - Lituania 6
UY - Uruguay 6
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
JO - Giordania 5
PY - Paraguay 5
TH - Thailandia 5
AL - Albania 4
GT - Guatemala 4
KR - Corea 4
PA - Panama 4
PE - Perù 4
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
LB - Libano 3
OM - Oman 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
KG - Kirghizistan 2
LI - Liechtenstein 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BM - Bermuda 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
Totale 8.574
Città #
Ashburn 636
Singapore 567
San Jose 385
Ferrara 219
Santa Clara 213
Hong Kong 190
Council Bluffs 187
Beijing 165
Fairfield 155
Chandler 154
Ann Arbor 125
Dallas 104
Houston 100
New York 94
Woodbridge 92
Ho Chi Minh City 91
Los Angeles 79
Seattle 77
Warsaw 71
Wilmington 69
Cambridge 68
Hanoi 64
Jakarta 64
The Dalles 61
Tokyo 58
São Paulo 53
Bologna 51
Jacksonville 51
Milan 51
Rome 51
Munich 50
Lauterbourg 46
Helsinki 45
Princeton 39
Shanghai 32
San Diego 27
Montreal 26
Orem 25
Phoenix 25
Mexico City 24
Chicago 23
Modena 23
Buffalo 22
London 22
Toronto 22
Ferrara di Monte Baldo 21
Izmir 21
Nuremberg 21
Atlanta 20
Brussels 19
Boston 18
Chennai 18
Boardman 17
Brooklyn 17
Turku 16
Frankfurt am Main 15
Da Nang 14
Washington 14
Hefei 13
Brasília 12
Dong Ket 12
Naples 12
Newark 12
Perugia 12
Poplar 12
San Francisco 12
Amsterdam 11
Denver 11
Falls Church 11
Jeddah 11
Lappeenranta 11
Belo Horizonte 10
Moscow 10
Ankara 9
Dhaka 9
Dublin 9
Manchester 9
Mumbai 9
Stockholm 9
Tashkent 9
Verona 9
Guangzhou 8
Haiphong 8
Nanjing 8
North Bergen 8
Querétaro 8
Rio de Janeiro 8
Brno 7
Johannesburg 7
Kingston 7
Ninh Bình 7
Redwood City 7
Tianjin 7
Turin 7
Vienna 7
Austin 6
Bogotá 6
Charlotte 6
Istanbul 6
Nanchang 6
Totale 5.405
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 330
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 321
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 289
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 288
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 271
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 263
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 259
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 259
Interactions between herpesviruses and the human immune system in old age 234
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 223
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 214
A new approach to UV protection by direct surface functionalization of TiO2 with the antioxidant polyphenol dihydroxyphenyl benzimidazole carboxylic acid 212
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 211
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 208
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 205
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment 204
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 201
Donation programme of returned medicines: Role of donors and point of view of beneficiaries 194
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 191
Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines 190
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 187
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 182
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 167
Antiretroviral Therapy Partially Restores Phenotypic and Metabolic Immunosenescence Features of T Cells in Hiv Infected Individuals 166
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 166
Synthesis and Evaluation of a ZnO-Chitosan Adduct for Safe and Sustainable Enhanced Ultra-Violet (UV) Sunscreens Protection 160
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 152
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 149
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 148
Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cells 144
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 138
ANTIRETROVIRAL THERAPY RESTORES NAÏVE T CELL FREQUENCIES OC 8 AND FUNCTIONALITY IN PLWH 131
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients 131
Synthesis and characterization of new multifunctional self-boosted filters for UV protection: ZnO complex with dihydroxyphenyl benzimidazole carboxylic acid 118
Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective 117
Angry, Hungry T-Cells: How Are T-Cell Responses Induced in Low Nutrient Conditions? 115
Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to Vaccination 114
Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania 112
IMMUNOSENESCENCE FEATURES ARE PARTIALLY RESTORED BY ANTIRETROVIRAL THERAPY 106
Cutting edge: A dual TLR2 and TLR7 ligand induces highly potent humoral and cell-mediated immune responses 104
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells 101
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old 100
Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries 95
Relationship between vaccination and nutritional status in children: Analysis of recent demographic and health surveys 94
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents 90
Rutin-containing cyclodextrin nanosystems: a possible strategy for dietary supplementation in diabetics 90
Old and new coronaviruses in the elderly 89
The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro 86
Aging and inflammation limit the induction of SARS-CoV-2–specific CD8+ T cell responses in severe COVID-19 82
Harnessing the induction of CD8+ T-cell responses through metabolic regulation by pathogen-Recognition-receptor triggering in antigen presenting cells 82
Immunological considerations regarding parental concerns on pediatric immunizations 74
Perceptions on vaccines, vaccine communication and information needs of healthcare professionals involved in older adult vaccination: A cross-country interview study 49
null 49
null 43
Editorial: Lipids in immunometabolism 21
Impact of cytomegalovirus infection on heterologous vaccine responsiveness 20
Totale 8.739
Categoria #
all - tutte 45.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022291 0 0 0 15 12 13 33 18 40 29 33 98
2022/2023385 45 19 17 48 47 41 42 48 44 2 22 10
2023/2024388 34 37 14 13 26 52 22 24 8 16 42 100
2024/20251.514 44 37 137 96 162 113 63 68 283 164 182 165
2025/20263.953 370 143 321 452 553 267 512 226 360 421 215 113
2026/2027960 145 202 346 267 0 0 0 0 0 0 0 0
Totale 8.739